Inhibition of interleukin-2 production by myricetin in mouse EL-4 T cells

Archives of Pharmacal Research

Volumn 30, Issue 9, 2007, Pages 1075-1079

  Cho, Young Chang ^a   Yoon, Goo ^a   Kwang, Youl Lee ^a   Hyun, Jin Choi ^a   Bok, Yun Kang ^a  

^a Chonnam National University   (South Korea)

Author keywords

IL 2; Myricetin; T cell

Indexed keywords

EID: 34848825889     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02980240     Document Type: Article

References (24)

1. Crabtree, G. R., Contingent genetic regulatory events in T lymphocyte activation. Science, 243, 355-361 (1989).
2. De Whalley, C. V., Rankin, S. M., Hoult, J. R., Jessup, W., and Leake, D. S., Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol., 39, 1743-1750 (1990).
3. Diehn, M., Alizadeh, A. A., Rando, O. J., Liu, C. L., Stankunas, K., Botstein, D., Crabtree, G. R., and Brown, P. O., Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. U.S.A., 99, 11796-11801 (2002).
4. Ghosh, P., Tan, T. H., Rice, N. R., Sica, A., and Young, H. A., The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. U.S.A., 90, 1696-1700 (1993).
5. Green, D. R., Droin N., and Pinkoski, M., Activation-induced cell death in T cells. Immunol. Rev., 193, 70-81 (2003).
6. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B., and Kromhout, D., Dietary antioxidant flavonoids and risk of coronary heart disease. Lancet, 342, 1007-1011 (1993).
7. Hoyos, B., Ballard, D. W., Bohnlein, E., Siekevitz, M., and Greene. W. C., Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science, 244 (1989).
8. Kang, B. Y., Kim, S. H., Cho, D., and Kim, T. S., Inhibition of interleukin-12 production in mouse macrophages via decreased nuclear factor-kappaB DNA binding activity by myricetin, a naturally occurring flavonoid. Arch. Pharm. Res., 28, 274-279 (2005).
9. Kempuraj, D., Madhappan, B., Christodoulou, S., Boucher, W., Cao, J., Papadopoulou, N., Cetrulo, C. L., and Theoharides, T. C., Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol., 145, 9349-9344 (2005).
10. Kuhnau, J., The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet, 24, 117-191 (1976).
11. Maggirwar, S. B., Harhaj, E. W., and Sun, S. C., Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-κB/Rel transcription factors. Mol. Cell. Biol., 17, 2605-2614 (1997).
12. Malek, T. R. and Bayer, A. L., Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4, 665-674 (2004).
13. Moien-Afshari, F., McManus B. M., and Laher, I., Immunosuppression and transplant vascular disease: benefits and adverse effects. Pharmacol. Ther., 100, 141-156 (2003).
14. Morgan, D. A., Ruscetti F. W., and Gallo, R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science, 193, 1007-1008 (1976).
15. Nel, A. E., T-cell activation through the antigen receptor. J. Allergy Clin. Immunol., 109, 758-770 (2002).
16. Ono, K., Nakane, H., Fukushima, M., Chermann, J. C., and Barre-Sinoussi, F., Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur. J. Biochem., 190, 469-476 (1990).
17. Ouyang, W., Ranganath, S. H., Weindel, K., Bhattacharya, D., Murphy, T. L., Sha, W. C., and Murphy, K. M. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity, 9, 745-755 (1998).
18. Rao, A., Luo, C., and Hogan, P. G., Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol., 15, 707-747 (1997).
19. Rooney, J. W., Sun, Y. L., Glimcher, L. H., and Hoey, T., Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol., 15, 6299-6310 (1995).
20. Rothenberg, E. V. and Ward, S. B., A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc. Natl. Acad. Sci. U.S.A., 93, 9358-9365 (1996).
21. Shapiro, V. S., Truitt, K. E., Imboden, J. B., and Weiss. A., CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol., 17, 4051-4058 (1997).
22. Smith, K. A., Interleukin-2. Curr. Opin. Immunol. 4, 271-276 (1992).
23. Truneh, A., Albert, F., Golstein, P., and Schmitt-Verhulst, A. M., Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature, 313, 318-320 (1985).
24. Wollenweber, E., Flavones and flavonols, Chapman and Hall, London, 189-259 (1982).